Systemic features in chronic obstructive pulmonary disease;Zmiany ogólnoustrojowe u chorych na przewleklq obturacyjnq chorobç ptuc

Pneumonologia i Alergologia Polska

Volumn 77, Issue 2, 2009, Pages 180-185

  Batura Gabryel, Halina ^a  

^a Pulmonologicznej Uniwersytetu Medycznego   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST OF ILLNESS; HEALTH; HEALTH PROMOTION; HUMAN; ORGANIZATION AND MANAGEMENT; PRIMARY PREVENTION; PULMONOLOGY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; WORLD HEALTH ORGANIZATION;

CHRONIC DISEASE; COST OF ILLNESS; HEALTH PROMOTION; HUMANS; PRIMARY PREVENTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; QUALITY OF LIFE; RESPIRATORY TRACT DISEASES; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 69849111173     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Rabe K.F., Hurd S., Anzuelo A. i wsp. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am. J. Respir. Crit. Care'Med. 2007; 176: 532-555.
2. Agusti A.G.N. COPD, a multicomponent disease: implications for management, Respir. Med. 2005; 99: 670-682.
3. Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A.G. Mortality in COPD: role of comorbidities. Eur. Respir. J. 2006; 28: 1245-1257.
4. Batura-Gabryel H., Kaminska-Kuznar B. Nowe spojrzenie na przewlekla, obturacyjna, chorobě, plue (POChP) - problem chorób wspóŁistniejacycych. Przew. Lek. 2007; 3: 98-101.
5. Fabbri L. M, Luppi F., Beghe B., Rabe K.F, Complex chronic comorbidities of COPD Eur. Respir. J. 2008; 31: 204-212.
6. Sevenoaks M.J., Stockley R.A. Chronic obstructive pulmonary disease, inflammation and co-morbidity -a common inflammatory phenotype? Respir. Res. 2006; 7: 70.
7. Redelmeier D.A., Tan S.H., Booth G.L. The treatment of unrelated disorders in patients with chronic medical, diseases. N. Engl. J. Med. 1998; 338: 1516-1520.
8. Pinto-Plata V.M., Milllerova H., Toso J.F. i wsp. C-reactive protein in patients with COPD, control smokers and. non-smokers. Thorax. 2006; 61: 23-28.
9. Takabatake N., Nakamura H., Abe S. i wsp. The relationship between chronic hypoxemia and activation of the Tumor Necrosis Factor-a System in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 161: 1179-1184.
10. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59: 574-580.
11. Fabbri L.M., Rabe K.F. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370: 797-799.
12. Batura-Gabryel H. WpŁyw POChP na choroby wspolistniejace. Terapia 2008; 9: 72-75.
13. Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
14. Lee S.H., Goswami S., Grudo A. i wsp. Antielastin autoimmunity in tobacco smoking-induced emphysema, Nat, Med. 2007; 13: 567-569.
15. Agusti A., MacNee W., Donaldson K., Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax 2003; 58: 832-834.
16. Similowski T., Agusti A.G., MacNee W., Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur. Respir. J. 2006; 27: 390-396.
17. Chatila W.M., Thomashow B.M., Minai O.A., Criner G.J., Make BJ. Comorbidities in Chronic Obstructive Pulmonary Disease. Proc. Am. Thorac Soc. 2008; 5: 549-555.
18. vanWeel C Chronic diseases in general practice: the longitudinal dimension, Eur, J. Gen, Pract. 1996; 2: 17-21,
19. van Manen J.G., Bindeis PJ., Ijzermans C.J. i wsp. Prevalence of comorbidity in patients with chronic airway obstruction and controls over the age of 40. J. Clin. Epidemiol. 2001; 54: 287-293.
20. Viegi G., Pistelli F., Sherrill D.L., Mlaio S., Baldacci S., Carrozzi L. Definition, epidemiology and natural history of COPD. Eur. Respir. J. 2007; 30: 093-1013.
21. Antonelli Incalzi R., Fuso L., De Rosa M. i wsp. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur. Respir. J. 1997; 10: 2794-2800.
22. Soler J.J., Sanchez L., Roman P. i wsp. Prevalence of malnutrition in outpatients with stable chronic obstructive pulmonary disease. Arch. Bronchopneumonol. 2004; 40: 250-258.
23. Kuznar-Kaminska B., Batura-Gabryel H., Brajer B., Kamienski J. Ocena zaburzen stanu odżywienia chorych na przewlekla. obturacyjna, chorobě plue. Pneumonol. Alergol. Pol. 2008; 5: 327-333.
24. Schols A.M., Buurman W.A., Staal van den Brekel A.J., Dentener M.A., Wouters E.F. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-824.
25. Creutzberg E.C., Wouters E.F., Vanderhoven-Augustin I.M., Dentener M.A., Schols A.M. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 162: 1239-1245.
26. Wouters E.F. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin. Chest Med. 2000; 21:753-762.
27. Gosker H.R., Hesselink M.K., Duimel H., Ward K.A., Schols A.M. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur. Respir. J. 2007; 30: 73-79.
28. Rabinovich R.A., Bastos R., Ardite E. i wsp. Mitochondrial dysfunction in COPD patients with low body mass index. Eur. Respir. J. 2007; 29:643-650.
29. Sidney S., Sorel M., Quesenberry C.P., DeLuise C., Lanes S., Eisner M.D. COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanent Care Program, Chest 2005; 128: 2068-2075.
30. Anthonisen N.R., Connett J.E., Enright P.L., Manfreda J. Lung Health Study Research Group: Hospitalization and mortality in the Lung Health Study. Am. Respir. Crit. Care Med. 2002; 166: 333-339.
31. Maclay J.D., McAllister D.A., MacNee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007; 12:634-641.
32. McAllister D.A., Maclay J.D., Mills N.L. i wsp. Arterial stiffness is independently associated, with emphysema severity in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 176: 1208-1214.
33. Mannino D.M., Aguayo SM., Petty T.L., Redd S.C Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up. Arch. Intern. Med. 2003; 163: 1475-1480.
34. Lange P., Nyboe J., Appleyard M., Jansen G., Schnohr P. Ventilatory function and chronic mucous hypersecretion as predictors of death from lung cancer. Am. Rev. Respir. Dis. 1990; 141: 613-617.
35. Ionescu A.A., Schoon E, Osteoporosis in chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 22: 64-75.
36. Hill K., Geist R., Goldstein R.S., Lacasse Y. Anxiety and depression in end-stage COPD. Eur. Respir. J. 2008; 31: 667-677.
37. Mikkelsen R.J., Middelboe T., Pisinger C., Stage K.B. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A Rev. Nordic J. of Psychiatry, 2004; 58: 65-70.
38. Jaracz J. Depresja i lek w przewleklych chorobách plue. Przewodnik Lekarza 2007 supl. 1: 139-141.
39. Baker E.H., Janaway C.H., Philips B.J i wsp. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61: 284-289.
40. Cote C., Zilberberg M.D., Mody S.H. i wsp. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur. Respir. J. 2007; 29:923-929.
41. John M., Hoernig S., Doehner W., Okonko D.D., Witt C., Anker S.D. Anemia and inflammation in COPD. Chest 2005; 127: 825-829.
42. Mannino D.M., Shorr A.F., Doyle J.J i wsp. Prevalence of anemia in subjects with chronic obstructive pulmonary disease. Proc. Am. Thorac Soc. 2006; 3: A615.
43. Similowski T., Agusti A.G., MacNee W., Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur. Respir. J. 2006; 27: 390-399.